High Affinity Antibodies Notes
High Affinity Antibodies in Neutralizing Pathogen Molecules
Introduction
- This section focuses on the role of high affinity antibodies in neutralizing the function of pathogen molecules.
- This mechanism relies on soluble high affinity antibodies, with IgG and IgA isotypes being particularly effective.
Neutralization Defined
- Neutralization occurs when an antibody binds to a pathogen or its virulence factor (e.g., adhesion molecule, toxin).
- This binding renders the pathogen or virulence factor non-infectious or non-pathogenic.
- Neutralization requires specific antibody binding to critical sites on the molecule.
Requirements for Neutralizing Activity
Sufficient Concentration:
- The antibody must be secreted in high enough concentrations to neutralize all of the pathogen's virulence factors.
- If there is more toxin than antibody, neutralization will not be effective.
Correct Epitope Binding:
- The antibody must bind to the pathogen or virulence factor at the correct epitope to antagonize its molecular function.
- Example: MERS-CoV RBD (Receptor Binding Domain) and DPP4
- MERS-CoV (related to SARS-CoV-2) uses its spike protein to bind to the DPP4 receptor on epithelial cells.
- Neutralizing antibodies like MERS VH55 bind to the spike protein at the DPP4 binding site, preventing virus-host cell interaction.
- Vaccines against COVID-19 aim to elicit neutralizing antibodies against the spike protein to block host receptor binding.
High Affinity Binding:
- The antibody must bind with high enough affinity to effectively neutralize the target molecule.
- High affinity antibodies have V domains that fit the antigen perfectly.
- Biological affinity depends on on rates and off rates:
- On rate: How quickly two molecules bind.
- Off rate: How quickly two molecules dissociate.
- High affinity is characterized by a low off rate, meaning the antibody binds tightly and doesn't easily dissociate.
Importance of Antibody Concentration: IgE vs. IgG/IgA
- IgE is not an effective neutralizing antibody because it is primarily found on mast cells and eosinophils, not in soluble form in serum where it can encounter pathogens.
- IgG and IgA are the primary antibody classes capable of neutralization due to their presence in sufficient concentrations in serum and other bodily fluids.
Examples of Neutralization
Blocking Adhesion:
- Antibodies bind to adhesions on microorganisms, preventing them from binding to host receptors on epithelial cells.
- This prevents the microorganism from penetrating epithelial barriers (e.g., in the gut).
Blocking Intracellular Infection:
- Antibodies bind to viral receptors (e.g., spike protein on coronaviruses), preventing them from binding to host receptors.
- This prevents the virus from infecting cells.
Neutralizing Toxins:
- Antibodies bind to toxins secreted by bacteria, preventing the toxins from binding to their receptors on host cells.
- This binding prevents the toxin from exerting its pathological effects (e.g., cell necrosis).
- Example: Cholera vaccine induces high affinity antibodies against cholera toxin, preventing it from binding to epithelial cell receptors and causing diarrhea.
Clinical Uses of Neutralizing Antibodies
Checkpoint Inhibitors in Cancer Therapy:
- Neutralizing antibodies against inhibitory molecules like CTLA-4 and PD-1 on T cells are used to treat cancer.
- These antibodies prevent the inhibitory signals, allowing T cells to remain active and kill cancer cells.
Cytokine Neutralization:
- Neutralizing antibodies against cytokines like TNF (Tumor Necrosis Factor) are used to treat inflammatory diseases.
- Infliximab is a monoclonal antibody against TNF, used in rheumatoid arthritis and inflammatory bowel disease.
Conclusion
- High affinity antibodies play a crucial role in neutralizing pathogens and preventing infection by blocking adhesion, intracellular infection, and neutralizing toxins.
- Neutralizing antibodies have various clinical applications, including cancer therapy and treatment of inflammatory diseases.